£25.0M
The Oxford-based medical technology company secured backing from Lauxera Capital Partners to expand its US footprint and advance research pipelines.
OrganOx
OrganOx builds automated perfusion devices to preserve donor livers for transplantation.
£29.6MTotal raised
OrganOx is a medical technology company that develops automated normothermic machine perfusion devices for liver transplantation. Its flagship product, metra, preserves donor livers and allows surgeons to assess function prior to transplant.
Categories
Team
Craig Marshall
Chief Executive Officer
Craig brings operational experience from executive roles at OrganOx and Siemens Magnet Technology. He currently serves as a venture partner at Amadeus Capital Partners alongside non-executive directorships.
LinkedInOS
Oern Stuge
Executive Chairman
Investors
- £25.0M
- £4.6MBGFLead
Funding history
£4.6M
The investment from BGF will support the rollout of the metra liver preservation system in the United States.